Ralph McMurray of Suffolk, England, was 66 years old when he had his first ever eye examination. It revealed he had eye cancer. According to a local news report, the examining optometrist found a detached retina and referred McMurray to the West Suffolk Hospital for further tests, which revealed a large tumor in his eye [..] Read More…
Proper Training Expected to Substantially Reduce Mortality Rates The Eye Cancer Foundation is pleased to announce a partnership with the International Council of Ophthalmology (ICO) to promote and conduct eye cancer fellowship education for physicians from unserved countries. The ICO represents and serves professional associations of ophthalmologists from around the world. The organization’s mission is [..] Read More…
The following was originally published by The Eye Cancer Foundation. The Summer 2016 edition of The Visionary is now available! The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research, and global efforts focused on improving eye cancer treatment, diagnosis, and cure. In this edition, you will find [..] Read More…
We are fortunate to have partnered with Hans Grossniklaus, MD, MBA who is founding director of the Ocular Oncology and Pathology Services at Emory Eye Center. Through this partnership, The Eye Cancer Foundation (ECF) is continuing its work supporting fellowship education for doctors from unserved countries. Dr. Hans E. Grossniklaus will host one ECF fellow [..] Read More…
Dr. Ahmad Shokri Zewar from Yemen was the first author of a recent study to evaluate the features and outcomes relating to the management of uveal melanoma in King Hussein Cancer Center in Jordan. Zewar conducted the study with Dr. Yacoub A.Yousef, a collaboration that was possible thanks to The Eye Cancer Foundation’s Fellowship program [..] Read More…
“Think of sunglasses as sunblock for your eyes,” is an oft-repeated slogan around the New York Eye Cancer Center. While most people tend to think of sunglasses as just a fashion statement, they may actually be a key defense against eye cancer. Sun causes damage to eye tissues just like it does to skin – [..] Read More…
The following is a statement from The Eye Cancer Foundation, reprinted here with their permission: The Eye Cancer Foundation (ECF) today announces a bold new strategic direction with a focus on bringing patients in every country access to an #EyeCancerCure. This will be accomplished through the Eye Cancer Working Day events, sponsored fellowships to train [..] Read More…
Dr. Finger recently attended the 2016 Commission on Cancer Spring Meeting in Chicago. It was an opportunity to not only network with other cancer doctors from around the United States, but to plan and move forward a number of initiatives that will benefit the eye cancer care community and its patients. Dr. Finger serves as [..] Read More…
A relatively new treatment for retinoblastoma quickly gaining popularity has shown some promise, but a systematic review of reported outcomes published in March provides some reason for caution. Intra-arterial chemotherapy has rapidly emerged as a treatment for intraocular retinoblastoma, the most common primary childhood eye cancer. It involves inserting a microcatheter into the ophthalmic artery [..] Read More…
Data released Monday to coincide with World Retinoblastoma Awareness Week (May 8-15) reveals a troubling lack awareness of this deadly form of eye cancer. Retinoblastoma is the most common eye cancer in young children. If not detected early, it’s also the most life-threatening. Each year, doctors diagnose more than 5,000 new cases of retinoblastoma. If [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
